Science Explorer Interactive view Map
Company · Solna · Sweden

Asarina Pharma (Sweden)

asarinapharma.comROR OpenAlex
Research works
14
▼ 3% vs 2013–17
Citations
197
14.5 per fractional work
Top-10% rate
31.0%
record average 16.5%
Open access
63%
world 28%

Not ranked overall: Asarina Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.26× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.10× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.62× its world share, 0 worksImmunology and Micro…Neuroscience: 22.95× its world share, 2 worksNeuroscienceChemistry: 0.78× its world share, 0 worksChemistryMedicine: 2.56× its world share, 3 worksMedicineNursing: 2.49× its world share, 0 worksNursingPsychology: 0.80× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 22.9×. Every wedge is a field page.

Which research topics does Asarina Pharma (Sweden) publish most on?

By volume in 2022–2025: Neuroscience and Neuropharmacology Research, Neuroinflammation and Neurodegeneration Mechanisms, Liver Disease Diagnosis and Treatment and Chronic Myeloid Leukemia Treatments.

Neuroscience and Neuroph…1Neuroscience and Neuropharmacology Research: 1 fractional worksNeuroinflammation and Ne…1Neuroinflammation and Neurodegeneration Mechanisms: 1 fractional worksLiver Disease Diagnosis …0Liver Disease Diagnosis and Treatment: 0 fractional worksChronic Myeloid Leukemia…0Chronic Myeloid Leukemia Treatments: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksNuclear Receptors and Si…0Nuclear Receptors and Signaling: 0 fractional worksStress Responses and Cortisol: 0 fractional worksPrenatal Screening and Diagnostics: 0 fractional worksMenopause: Health Impacts and Treatments: 0 fractional works
Cellular and Molecular NeuroscienceNeurologyEpidemiologyHematology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 1 works
  2. 2 Neuroinflammation and Neurodegeneration Mechanisms Neurology 1 works
  3. 3 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
  5. 5 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 0 works
  7. 7 Nuclear Receptors and Signaling Cellular and Molecular Neuroscience 0 works
  8. 8 Stress Responses and Cortisol Behavioral Neuroscience 0 works
  9. 9 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 0 works
  10. 10 Menopause: Health Impacts and Treatments Endocrinology, Diabetes and Metabolism 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available63.4%not open36.6%

World: 28% of research is openly available.

with international co-authors45.5%domestic only54.5%

World: 19% is written across borders.

How has Asarina Pharma (Sweden)'s research output changed?

Output in 2018–2022 was 3% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.